N4 Pharma Plc

N4 Pharma (N4P)

Company name:N4 Pharma Plc
EPIC:N4PTrading Currency:GBX
Market Sector:AMQ1ISIN:GB00BYW8QM32
Market Segment:ASQ1Share Type:DE
WWW Address:https://www.n4pharma.com/investorsDescription:ORD 0.4P
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 3.50 images.advfn.com/imagesnew/2/gb/dot 0.0 [0.00] 3.30 3.70 3.50 3.50 3.50 86,333
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 3.55 101.46 0.00 -1.32 - - - 15.20 - 2.65

N4 Pharma Key Figures

(at previous day's close)
Market Cap.3.55m
Shares In Issue101.46m
Prev. Close3.50
PE Ratio- 
Dividend Yield-%
EPS - basic-1.32p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-1.32p
Return On Equity (ROE)-134.65%
Operating Margin-%
PEG Factor- 
EPS Growth Rate-4.76%
Dividends PS Growth Rate-%
Net Debt-0.60m
Gross Gearing17.77%
Quick Assets1.07m
Net Working Capital0.88m
Intangibles / Fixed Assets-%
Turnover PS-p
Pre-Tax Profit PS-1.37p
Retained Profit PS-1.17p
Cash PS0.78p
Net Cash PS0.59p
Net Tangible Asset Value PS *0.87p
Net Asset Value PS0.87p
Spread0.40 (10.81%) 
* Calculation based on Ordinary Capital figure as contained in last annual report, and the most recent shares in issue figure. Therefore the ratio might be exposed to inaccuracies.

N4 Pharma Balance Sheet

LSE:N4P:Liabilities+EQLSE:N4P:Assets

Share Price Performance

Sample Period †HighLow
1 week3.853.00
4 weeks3.852.65
12 weeks3.852.65
1 year15.202.65

Share Price Chart (5 years)

N4 Pharma Historic Returns

Period †OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week3.000.5016.673.000.663.62
4 weeks2.800.7025.002.650.373.30
12 weeks3.150.3511.112.650.303.17
26 weeks5.30-1.80-33.962.650.513.79
1 year10.65-7.15-67.142.650.735.46
3 years6.75-3.25-48.152.650.8811.07
5 years6.75-3.25-48.152.650.8811.07
† periods calculated are whole weeks rather than calendar months

N4 Pharma Key Management Ratios

N4 Pharma Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 2.81 
Tobin's Q Ratio (excl. intangibles)2.81 
Dividend Yield-%
Market-to-Book Ratio4.04 
Price-to-Pre-Tax Profit PS-2.55 
Price-to-Retained Profit PS-3.00 
Price-to-Cash Flow PS-2.64 
Price-to-Sales PS- 
Price-to-Net Tangible Asset Value PS4.04 
Price-to-Cash PS4.48 
Net Working Capital PS0.87 
Price Pct to Working Capital PS4.04%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

N4 Pharma Financial Ratios

(Leverage Ratios)
Debt Ratio-%
Debt-to-Equity Ratio- 
Debt-to-Equity Ratio (excl. Intgbl)- 
Debt-to-Equity Market Value- 
Net Gearing-56.35%
Net Gearing (excl. Intangibles)-56.35%
Gross Gearing17.77%
Gross Gearing (excl. Intangibles)17.77%
Gearing Under 1 Year17.77%
Gearing Under 1 Year (excl. Intgbl)17.77%
Assets/Equity1.22 
Cash/Equity90.14 
(Liquidity Ratios)
Net Working Capital to Total Assets82.23%
Current Ratio5.63 
Quick Ratio (Acid Test)5.63 
Liquidity Ratio4.17 
Cash & Equiv/Current Assets74.12%
(Solvency Ratios)
Enterprise Value2.76m
CFO/Sales- 
CFO/Attributable Profit- 
CFO/Assets-1.26 
CFO/Debt-7.07 
Total Debt/Equity Market Value0.05 
Total Debt/Sales- 
Total Debt/Pre-Tax Profit-0.14 
Total Debt0.19m
Total Debt/Net Current Assets0.22%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs1 
Beta (60-Mnth)Beta (36-Mnth)
0.00400.0040

N4 Pharma Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-158.01%
Return On Assets (ROA)-93.70%
Net Profit Margin-%
Assets Turnover- 
Return On Equity (ROE)-134.65%
Return On Investment (ROI)-109.72%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-%
(Asset Utilisation Multiples)
Shareholders Equity Turnover- 
Fixed Assets Turnover- 
Current Assets Turnover- 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales- 
Debtors-to-Sales-%
Debt Collection Period-Days

N4 Pharma Dividends

Sorry No Data Available

N4 Pharma Fundamentals
 31 Dec 2017 (GBP)31 Dec 2018 (GBP)
turnover----m
pre tax profit-1.93--1.39-m
attributable profit-1.84--1.18-m
retained profit-1.84--1.18-m
eps - basic (p)-1.26 -1.32 
eps - diluted (p)-1.24 -1.30 
dividends per share- - 

N4 Pharma Balance Sheet

 31 Dec 2017 (GBP)31 Dec 2018 (GBP)
LSE:N4P:Liabilities+EQLSE:N4P:AssetsLSE:N4P:Liabilities+EQLSE:N4P:Assets
 31 Dec 2017 (GBP)31 Dec 2018 (GBP)
ASSETS
fixed assets fixed assets--%--%m
intangibles intangibles--%--%m
fixed investments fixed investments--%--%m
current assets - other current assets - other--%--%m
stocks stocks--%--%m
debtors debtors0.139.10%0.2825.88%m
cash & securities cash & securities1.3390.90%0.7974.12%m
TOTAL1.46100%1.07100%m
LIABILITIES
creditors - short creditors - short0.1812.28%0.1917.77%m
creditors - long creditors - long--%--%m
creditors - other creditors - other--%--%m
subordinated loans subordinated loans--%--%m
insurance funds insurance funds--%--%m
TOTAL0.1812.28%0.1917.77%m
EQUITY
ord cap, reserves ord cap, reserves1.2887.72%0.8882.23%m
prefs, minorities prefs, minorities--%--%m
TOTAL1.2887.72%0.8882.23%m
OTHER
NAV Basic- - 
NAV Diluted- - 

N4 Pharma Cash Flow Statement

31 Dec 2017 (GBP)31 Dec 2018 (GBP)
Operating CF-0.95-1.34m
Pre-Financing CF-0.55-1.32m
Retained CF1.31-0.53m

N4 Pharma Brokers

Broker infomation is not available for this class of stock.
Your Recent History
LSE
N4P
N4 Pharma
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20200126 01:39:01